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Malaria Enhances Expression of CC Chemokine Receptor 5 on Placental
Macrophages
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and Steven R. Meshnick1
Departments of 1Epidemiology, 2Otolaryngology, and 3Pathology,
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Malaria and human immunodeficiency virus (HIV) coinfections are common in pregnant
women in sub-Saharan Africa. The current study shows that placentas of malaria-infected
women contain 3 times as much CC chemokine receptor 5 (CCR5) RNA as placentas of
women without malaria. By immunohistochemistry, CCR5+ maternal macrophages were seen
in placentas from malaria-infected women but not in placentas from malaria-uninfected
women. In addition, CCR5 also was found on fetal Hofbauer cells in placentas from both
groups. Thus, malaria infections increase the potential reservoir for HIV in the placenta by
increasing the number of HIV target cells.
Malaria and human immunodeficiency virus type 1 (HIV-1)
are among the most prevalent infectious diseases in sub-Sa-
haran Africa, and coinfections are common [1]. These coinfec-
tions may be of great significance in pregnant women, because
it is possible that malaria may enhance mother-to-child trans-
mission of HIV. In a recent study in The Gambia, vertical
transmission rates for HIV-1 were twice as high during the rainy
malaria season than during the dry season [2]. This may have
been the result of an effect of malaria infection on viral rep-
lication. In vitro, exposure to malaria antigens causes increased
HIV replication in peripheral blood mononuclear cells [3]. In
Malawian adults, malaria infections were associated with 7-
fold higher HIV virus loads [4].
HIV cell entry is complex. HIV requires the CD4 molecule
plus another coreceptor for efficient entry. Several chemokine
receptors, especially CXCR4 and CCR5, appear to be important
coreceptors [5–9]. CCR5 appears to play an important role in
mother-to-child transmission of HIV: black infants who are ho-
mozygous for a promoter polymorphism (59396T) were at a 6-
fold higher risk of being infected than were heterozygotes or
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homozygotes [10]. However, little is known about the distribution
of chemokine receptors in the placenta [11].
About 20%–25% of HIV-infected infants become infected
within the uterus before delivery [12]. Infants infected in this
manner might be unaffected by short-course antiretroviral ther-
apies [11]. Because placentas of malaria-infected mothers often
contain high numbers of macrophages [13, 14] and because
placental macrophages can be reservoirs for HIV [15], we stud-
ied whether malaria infections might increase placental virus
load and promote intrauterine transmission of HIV.
Materials and Methods
Study population. Placental biopsy specimens were obtained
from participants in a prospective cohort study of primigravid
women in Mangochi, Malawi, and were frozen directly in liquid
nitrogen. This area of Malawi has high-level transmission of Plas-
modium falciparum. Recruitment of subjects and methods of eval-
uation were done as described elsewhere [16, 17].
All available placental biopsy specimens from women with cord
blood parasitemias were selected as the infected group ( ).n p 23
For the control group, placentas were used from women who had
no indication of malaria infection during pregnancy ( ). He-n p 21
mozoin levels were undetectable in the control group placentas,
and none of the women from this group had positive antenatal or
delivery parasitemia. Placental hemozoin concentrations were de-
termined as described elsewhere [18].
Ribonuclease protection assay. Total RNA was extracted from
the placental biopsy specimens, as described elsewhere [16]. Two
chemokine-specific riboprobe template sets, hCR-8 and hCD-1,
were used (BD Pharmingen). The hCR-8 template set contained
riboprobes specific for human STRL33, US28, CCR3, CCR5,
CXCR4, CCR8, GPR15, GPR1, V28, CCR2b, L32, and GAPDH.
The hCD-1 template set contained riboprobes specific for human
TCRd, TCRa, CD3e, CD4, CD8a, CD8b, CD19, CD14, CD45,
L32, and GAPDH. All riboprobe syntheses and subsequent steps
of probe purification, placental RNA (15 mg) probe hybridization,
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Table 1. Placental chemokine receptor and surface marker mRNA










CD4 0.166 5 0.067 0.158 5 0.056 1.05 NS
CD14 0.422 5 0.112 0.412 5 0.101 1.02 NS
CCR5 0.028 5 0.032 0.009 5 0.004 3.11 .01
CCR3 0.026 5 0.031 0.009 5 0.005 2.89 .03
CXCR4 0.091 5 0.058 0.067 5 0.018 1.36 .07
NOTE. Data are , unless otherwise indicated. NS, not significant.mean 5 SD
a Calculated from the ratio of volume of signal to that of L32, a housekeeping
gene, in the same lane on the gel.
RNase treatment, and purification of protected RNA duplexes were
done as described elsewhere [16]. Protected RNA was resolved by
gel electrophoresis, using the QuickPoint Rapid Nucleic Acid Sep-
aration System (NOVEX), according to the manufacturer’s instruc-
tions. Radiolabeled, protected RNA bands were visualized by using
a phosphorimager (Storm series 400) and were quantified by using
ImageQuant software (both from Molecular Dynamics), as de-
scribed elsewhere [16, 19]. Each sample was analyzed in 2 separate
experiments, and the relative phosphorimager values obtained were
averaged. Duplicates were !20% of each other. Each probe was
normalized against the internal housekeeping signal (L32), to con-
trol for variability in each assay, as described elsewhere [16].
Immunohistochemistry (IHC) and immunofluorescence. Frozen
placental tissue sections were prepared, fixed, and stored, as described
elsewhere [16]. A frozen lymph node biopsy specimen from a patient
with malignant lymphoma was used as the positive control tissue.
The incubations detailed below were done at room temperature.
IHC single-staining procedure. Tissue sections were rehydrated
in PBS (Life Technologies Gibco BRL) containing 0.1% bovine
serum albumin (BSA, ELISA-grade; Sigma), were rinsed in deion-
ized water, and then were incubated in 1% H2O2 (diluted in PBS
and 0.1% BSA) for 30 min, to neutralize endogenous peroxidase
activity. After slides were rinsed in deionized water and then in
PBS and 0.1% BSA, samples were treated with 1:10 dilution of
blocking serum (normal goat serum [BioGenex] diluted in PBS and
0.1% BSA) for 30 min. The slides were then exposed (for 30 min
to 1 h) to 4 mg/mL anti-human CCR5 (clone 2D7), 2 mg/mL anti-
human macrophage mannose receptor (clone 19.2), or 2 mg/mL
anti-human macrophage CD68 (clone KP1). All were monoclonal
antibodies purchased from Pharmingen. Purified mouse IgG1 (2
mg/mL), k isotype standard (clone MOPC-21), was used as the
control antibody for anti-CD68 anti-mannose receptor staining,
whereas purified mouse IgG2a (4 mg/mL), k isotype standard (clone
C1.18.4), was used as a control for the anti-CCR5–specific anti-
body. After being treated with antibodies, the slides were rinsed
with PBS and 0.1% BSA and then were incubated for 15 min with
biotin-conjugated goat anti-mouse immunoglobulin–specific poly-
clonal antibody (Vector Laboratories) diluted 1:200. All antibody
dilutions were done in common antibody diluent (BioGenex). The
samples were rinsed in PBS and 0.1% BSA and were treated for
15 min with preformed avidin and biotinylated horseradish per-
oxidase macromolecular complex reagent (Vectastain Elite; Vector
Laboratories) diluted 1:100. Samples then were rinsed with PBS/
0.1% BSA, were rinsed again with PBS only, and then were in-
cubated with the substrate 3-amino-9-ethyl carbazole (Vector Lab-
oratories). Color was allowed to develop for 10 min, and then the
samples were rinsed in PBS to stop the reaction. The slides then
were rinsed a final time in deionized water. Gill’s no. 1 hematoxylin
(Fisher Scientific) was used as a counterstain. Slides were mounted
with aqueous mounting media (Biomeda) and were allowed to dry
for 24 h before being viewed with a microscope.
Immunofluorescence double-staining procedure. Tissue sections
were rehydrated with PBS containing Triton X-100 (0.01%). They
were first incubated with rabbit polyclonal anti-CCR5 (10 mg/mL;
Chemicon International) for 1 h, and the slides then were washed
in PBS and were incubated with anti-rabbit IgG–fluorescein iso-
thiocyanate (Jackson Immunochemicals), 1:150, for 30 min. This
and all subsequent incubations were done in the dark. Slides were
washed with PBS, were incubated with prediluted anti-CD68
(Zymed) for 1 h, and then were washed with PBS again. The slides
then were incubated with anti-mouse IgG-Texas Red (Vector Lab-
oratories), 1:75, for 30 min, were washed with PBS, and then were
washed with water. Coverslips were mounted with aqueous mount-
ing media (Biomeda), and the slides were stored at 2207C until
viewed under a fluorescent microscope.
Statistical analyses. Analyses of means, SDs, and 2-tailed Stu-
dent t tests for unequal variances were done by use of Microsoft
Excel 97.
Results
Placental mRNA receptor expression associated with malaria
infection. Placental mRNA levels for CD4, CD14, CCR3,
CCR5, and CXCR4 were quantitated by ribonuclease protec-
tion assay and were normalized to the housekeeping gene L32
(table 1). There was no difference in CD4 or CD14 expression
between the control and infected groups, which suggests that
there was no difference in the population sizes of either CD41
T cells or macrophages and dendritic cells that are CD141. Of
interest, there was also no difference in expression levels for
CXCR4, a coreceptor for T-tropic HIV. However, expression
of CCR5, the coreceptor for M-tropic viruses, and CCR3 were
increased ∼3-fold in the infected placentas ( andP p .01 P p
, respectively)..03
Detection of CCR5 in placental tissue sections by IHC and
immunofluorescence. Increased expression of CCR5 could fa-
cilitate virus entry into macrophages. However, since CCR5 is
expressed on many cell types, we needed to know whether the
increase in placental CCR5 mRNA corresponds to increased
CCR5 expression on HIV-receptive cell types. Through IHC,
we identified 2 distinct cell populations that expressed the co-
receptor CCR5. In both the control and infected groups, the
CCR51 staining was most common on cells within the chorionic
villous, which appeared to be Hofbauer cells (figure 1E and
1F). Hofbauer cells are fetal macrophages located in the stroma
that are known to express CD68 and the anti-mannose receptor
[20, 21]. The same cells that stained with anti-CCR5 appeared
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Figure 1. Immunohistochemical staining for CD68 and CC chemokine receptor 5 (CCR5) in chorionic villi in placentas from malaria-infected
and nonparasitized mothers. Placental sections were stained with control IgG (A and B), anti-CD68 (C and D), and anti-CCR5 (E and F). A,
C, and E, Samples from a malaria-infected mother; B, D, and F, samples from a control placenta. CD68 staining pattern of stromal cells, which
are consistent with tissue macrophages or Hofbauer cells, is similar to CCR5 staining in both types of placentas. Original magnification, 3400.
to stain with anti-CD68 (figure 1C and 1D) and anti-mannose
receptor (not shown) but not with control IgG (figure 1A and
1B). Intervillous maternal macrophages also stained positively
for CCR5 (figure 2G–2I) but were found only in the placentas
from malaria-infected women. CCR5 is expressed on maternal
macrophages containing intracellular hemozoin and on mac-
rophages with no hemozoin. Similar appearing clusters of in-
tervillous macrophages also stained with anti-CD68 (figure
2D–2F), as expected [14], but not control IgG (figure 2A–2C).
To establish the identity of the CCR51 cells, we doubly
stained sections by immunofluorescence with anti-CCR5 and
anti-CD68. Anti-CD68 was used to identify both maternal mac-
rophages and Hofbauer cells. All CCR51 intervillous cells were
CD68 positive (figure 3A and 3B), confirming that they were
indeed macrophages. All CCR51 Hofbauer cells were CD68
positive (figure 3C and 3D) in both infected (shown) and un-
infected placentas (not shown). There was no staining with any
of the control antibodies (not shown).
Discussion
In this study, we compared CCR5 expression in placentas
from malaria-infected and uninfected women. In both types of
placentas, CCR5 is expressed on fetal Hofbauer cells. In ad-
dition, maternal macrophages express CCR5 in the malaria-
infected placentas. As determined on the basis of RNA levels,
CCR3 and CCR5 expression is increased 3-fold by malaria
infection. The increase appears to be selective, since there is no
increase in CD4, CD14, or CXCR4 RNA.
This is the first study, to our knowledge, of CCR5 expression
in situ in placentas. The observation of CCR5 on maternal
macrophages and fetal Hofbauer cells is consistent with pre-
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Figure 2. Immunohistochemical staining for CD68 and CC chemokine receptor 5 (CCR5) of individual and clusters of intervillous mononuclear
cells in placenta from malaria-infected mother. Cells were stained with control IgG (A–C), anti-CD68 (D–F), or CCR5-specific IgG (G–I). Brown
spots are hemozoin pigment. Original magnification, 31000.
vious studies of HIV-infected mothers, which demonstrated the
presence of HIV in these cells by IHC and in situ hybridization
[1, 22, 23]. The presence of CCR5 on both these cell types lends
credence to the possibility that they are involved in intrauterine
transmission of HIV.
There are several reasons to believe that CCR5 is important
in mother-to-child transmission of HIV in Africa. First, almost
all strains of HIV that are transmitted in this manner are CCR5-
trophic (M-trophic, R5) [24, 25]. Second, offspring of HIV-
infected black mothers who are homozygous for a CCR5-pro-
moter polymorphism have a 6-fold higher risk of being infected
at birth [10]. Thus, increases in placental CCR5 might indeed
be of clinical relevance in mother-to-child HIV transmission.
There was no apparent difference between infected and un-
infected placentas in the distribution or staining intensities of
CCR51 Hofbauer cells. The major difference appeared to be
that CCR51 maternal macrophages were present in the malaria-
infected group but were not present in the malaria-uninfected
group. Thus, it is likely that the difference in CCR5 RNA levels
between the 2 groups was due to its expression by maternal
macrophages. Previous studies have shown that malaria infec-
tions lead to the accumulation of maternal macrophages in the
placenta [13, 14]. In aggregate, evidence suggests that malaria
causes an increase in HIV-receptive maternal macrophages
within the placenta.
A modest number of maternal macrophages was seen in sec-
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Figure 3. Immunofluorescence double staining for CD68 (red) and CC chemokine receptor 5 (CCR5; green). Shown are an intervillous
macrophage stained for CD68 (A) and CCR5 (B) and a Hofbauer cell stained for CD68 (C) and CCR5 (D). Original magnification, 31000 (oil
immersion).
tions from infected placentas, and none was seen in sections
from uninfected placentas. Pronounced infiltration of the in-
tervillous spaces by mononuclear cells was not seen. However,
this usually only occurs in a small percentage of malaria-
infected placentas [13, 14]. In all sections of these placentas,
the fetal Hofbauer cells greatly outnumbered maternal mac-
rophages (data not shown). Since Hofbauer cells also produce
CD14 [26], it is not surprising that the levels of CD14 RNA
in infected and uninfected placentas were similar.
In this study, CCR5 was found on macrophages both with
and without hemozoin. The presence of hemozoin within the
macrophage is evidence that the cell had previously phagocy-
tosed either an intact malaria-infected erythrocyte or fragments
of parasites. Thus, our data suggest that phagocytosis of para-
site material does not directly induce CCR5. This contrasts with
our previous study, in which tumor necrosis factor–a and in-
terleukin-8 were expressed only in placental hemozoin-laden
maternal macrophages [16]. This suggests that CCR5 induction
may be indirectly induced by the proinflammatory cytokines
elicited in the placenta by malaria infections. Alternatively,
CCR5 expression may be in a dynamic state of up-regulation
and down-regulation on inflammatory cells during recruitment.
Interactions between malaria and HIV during pregnancy
have important public health consequences. HIV-infected preg-
nant women had more frequent and higher malaria parasitem-
ias [27, 28] and responded more poorly to presumptive anti-
malarial therapy [29]. Offspring of HIV- and malaria-coinfected
pregnant women in Malawi were 3–8 times more likely to die
in their first year of life than were offspring of mothers with
either HIV or malaria infections alone [30]. Mother-to-child
transmission of HIV-1 and HIV-2 was studied recently in The
Gambia, where malaria transmission occurs almost exclusively
during the rainy season [2]. HIV-1 and HIV-2 transmission
rates, which were 14.8% and 1.7%, respectively, in the dry sea-
son, rose to 29.4% and 7.1%, respectively, during the rainy
season. This effect was hypothesized to be due to an effect of
malaria, although malaria parasitemias were not assessed in
any of the mothers. In aggregate, these reports suggest that
coordinated efforts to prevent HIV and malaria in pregnant
women are needed.
Many of the women in this study may have been HIV in-
fected, and HIV could affect the immune environment of the
placenta [31]. Although no HIV tests were done at the time of
enrollment, reverse transcription–polymerase chain reaction
analysis was done on all the biopsy specimens, and they were
negative for HIV [16]. Nevertheless, some women in either
group could still have been infected with HIV. However, one
would not expect the incidence of HIV infection to be different
in the infected and uninfected groups; no association between
cord blood parasitemia and HIV infection was seen in a large
cohort study of malaria- and HIV-infected mothers [28].
In conclusion, CCR5 expression is increased in placentas of
malaria-infected women. Further studies are needed to determine
whether this increased expression could contribute to intrauterine
transmission of HIV. If such an association is found, it is possible
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that interventions to prevent maternal malaria might aid in the
prevention of mother-to-child HIV transmission.
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